Paluratide

Star0

DB21694InvestigationalSmall molecule

Paluratide is a small molecule drug. Paluratide has a monoisotopic molecular weight of 1436.79 Da.

Mechanism: Pharmacologically active on GTPase KRas
Curator reviewed
Formula / weight: C₇₃H₁₀₅F₅N₁₂O₁₂ · 1437.707 g/mol (avg)
Code names: LUNA18

Resolves to

Compound

UNIIAW3YP3CD9XCAS2676177-63-0ChEMBLCHEMBL6147825

Structure

InChIKeyZQVKVYRBKAEFPD-DEBTURSASA-NSMILES

CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@H](N(C)C(=O)[C@H](C2CCCC2)N(C)C(=O)C2(CCCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC2=CC(F)=C(C(F)=C2)C(F)(F)F)NC(=O)CN(C)C(=O)[C@H](CC2=CC=C(C)C=C2)N(CC)C(=O)[C@@H]2CCN2C(=O)[C@H](C)N(C)C1=O)C(=O)N(C)C

Targets

P01116KRAS

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Paluratide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account